J9232Inj docetaxel (hospira) 1 mg

Published CMS Medicare Part B payment-limit context for J9232, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.

CMS payment limit

$0.512

per 1 MG · Medicare Part B

Not availablePrior-quarter comparison not available

Current quarter: 2026-Q3FinalEffective July 1, 2026
Billing unit: 1 MG

Payment limit over time

$0.553$0.471

2024-Q4: Not published; 2025-Q1: Not published; 2025-Q2: Not published; 2025-Q3: Not published; 2025-Q4: Not published; 2026-Q1: Not published; 2026-Q2: Not published; 2026-Q3: $0.512

No current FDA shortage matchThe latest completed FDA data has no affected record matching the Docetaxel ingredient family (FDA data as of August 20, 2026).

Email me when FDA shortage status changes

Docetaxel

Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.

Other Docetaxel presentations

3 other CMS codes

Source-linked same ingredient-family context, not recommendations, substitutes, or clinical or billing equivalence.

Swipe to see all columns

HCPCS	CMS description	Current quarter 2026-Q3	Prior quarter 2026-Q2	Change
J9171	Docetaxel injection	$0.456 per 1 MG	$0.556 per 1 MG	Down 18.0%
J9172	Docetaxel (docivyx), 1 mg	$46.287 per 1 MG	$50.607 per 1 MG	Down 8.5%
J9174	Inj, docetaxel (beizray) 1mg	$46.808 per 1 MG	Not published	Not available

Put another code on your radar.

Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.

Explore CMS codes